Learnings for Health Economics from the Early Stages of the COVID-19 Pandemic Anthony J. Hatswell Editorial Open access 10 April 2020 Pages: 203 - 205
Group Testing for SARS-CoV-2: Forward to the Past? Koen B. PouwelsLaurence S. J. RoopePhilip M. Clarke Commentary Open access 28 April 2020 Pages: 207 - 210
A Systematic Review of Model-Based Economic Evaluations of Treatments for Venous Leg Ulcers Ashley LayerEmma McManusN. J. Levell Systematic Review Open access 27 May 2019 Pages: 211 - 222
Managing Uncertainties Due to Limited Evidence in Economic Evaluations of Novel Anti-Tuberculosis Regimens: A Systematic Review T. I. Armina PadmasawitriSarah Maria SaragihAnke M. Hövels Systematic Review Open access 11 July 2019 Pages: 223 - 233
Cost Effectiveness of PD-L1-Based Test-and-Treat Strategy with Pembrolizumab as the First-Line Treatment for Metastatic NSCLC in Hong Kong Herbert H. LoongCarlos K. H. WongSeng Chuen Tan Original Research Article Open access 17 September 2019 Pages: 235 - 247
Cost of Delivering Secondary Healthcare Through the Public Sector in India Shankar PrinjaAkashdeep Singh ChauhanThiagarajan Sundararaman Original Research Article Open access 29 August 2019 Pages: 249 - 261
Touch for Health: Use of Pavlovian Processes with Physical Touch as a Means to Improve Menstrual Hygiene Management Initiatives, Measured by Willingness to Pay Siobhan K. YilmazAlok K. BoharaSoumi Roy Chowdhury Original Research Article Open access 23 July 2019 Pages: 263 - 276
Cost-Effectiveness Analysis of Exenatide versus GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Margarita CapelAndreea CiudinItziar Oyagüez Original Research Article Open access 23 July 2019 Pages: 277 - 286
Health Technology Assessment of Drugs in Ireland: An Analysis of Timelines Emma ConnollyHelen O’DonnellMichael Barry Original Research Article Open access 17 September 2019 Pages: 287 - 296
Economic Evaluation of Azacitidine in Elderly Patients with Acute Myeloid Leukemia with High Blast Counts D. CoylePierre J. A. Villeneuve Original Research Article Open access 27 September 2019 Pages: 297 - 305
Ticagrelor Removal by CytoSorb® in Patients Requiring Emergent or Urgent Cardiac Surgery: A UK-Based Cost-Utility Analysis Mehdi JavanbakhtMiranda TrevorEric Mortensen Original Research Article Open access 16 October 2019 Pages: 307 - 319
Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands Judith J. Gout-ZwartLisa A. de JongMaarten J. Postma Original Research Article Open access 18 September 2019 Pages: 321 - 330
Impact of a Clinical Pharmacist Intervention on Medicine Costs in Patients with Chronic Obstructive Pulmonary Disease in India Suhaj AbdulsalimMazhuvancherry Kesavan UnnikrishnanAbubakr A. Alfadl Original Research Article Open access 31 July 2019 Pages: 331 - 342
Modelling Survival of Patients Treated with Adjuvant Nivolumab Who Have Melanoma with Lymph Node Involvement or Metastatic Disease After Complete Resection Rachael BattesonRose HartAdenike Amadi Original Research Article Open access 05 October 2019 Pages: 343 - 351
The Costs of Industry-Sponsored Drug Trials in Canada Dat T. TranIlke AkpinarPhilip Jacobs Original Research Article Open access 10 July 2019 Pages: 353 - 359
A Nationwide Study of Prevalence Rates and Characteristics of 199 Chronic Conditions in Denmark Michael Falk HvidbergSoeren Paaske JohnsenLars Ehlers Original Research Article Open access 24 July 2019 Pages: 361 - 380
Treatment Patterns and Costs Associated with Stage IV Non-Small Cell Lung Cancer in a Mexican Population: A Chart Review Jorge Arturo AlatorreSaúl Campos-GómezJimena María Iglesias-Chiesa Original Research Article Open access 27 August 2019 Pages: 381 - 388
Out-of-Pocket Cancer Care Costs and Value Frameworks: A Case Study in a Community Oncology Practice with a Financial Navigator Program Christine LeopoldCarina Araujo-LaneAnita K. Wagner Research Letter Open access 19 July 2019 Pages: 389 - 392